Atlas Trials

Radiomics-Based Visualization and Quantitative Validation of IDH1 Heterogeneity in Gliomas

Clinical trial NCT05969691 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05969691
Sponsor
Mingge LLC
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Glioma, MalignantComputer-Assisted
Start date
2019-03-15
Primary completion
2025-12-15
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.